The present invention relates to methods based on the interactions of
thrombin as a biological regulator. More specifically, the invention
relates to the interactions of thrombin with regard to Notch signaling,
Jagged1, PAR1, and cellular effects mediated thereby. The invention
relates to the discovery that thrombin cleaves Jagged1 to produce
non-membrane soluble Jagged1 (sJ1). The soluble Jagged1 protein can
affect Notch signaling and, among other things, mediate the release of
FGF-1 and/or IL-1.alpha. from a cell. The invention further relates to
the role(s) of thrombin and signaling via Notch proteins and the effect
on thrombosis, angiogenesis, and/or differentiation, among other
processes. Moreover, the invention relates to discovery that thrombin,
sJ1, and TRAP mediate, inter alia, rapid non-classical release of FGF-1,
and proteins associated therewith (e.g., p40 Syn1 and S100A13, among
others), and the effect growth and proliferation of a stem cell without
loss of differentiation potential. Thus, the present invention relates to
methods of clonally expanding a pluripotent stem cell while preserving
the differentiation potential of the cell, a process termed
"stamatogenesis."